drugset / Trial / NCT00125047
Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
Phase 4
Completed
27231 enrolled
International Vaccine Institute
Aga Khan University · collabGlaxoSmithKline · collabUniversity of Western Ontario, Canada · collabWellcome Trust · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is part of the International Vaccine Institute's (IVI's) typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The purpose of this study is to determine the effectiveness of the Vi vaccine following a mass typhoid immunization campaign in an endemic area in Karachi, Pakistan. The cost-effectiveness of Vi vaccination and the logistic feasibility of a mass typhoid immunization campaign will also be evaluated.
Timeline
- Start
- 2001-10
- Primary completion
- 2007-08
- Completion
- 2007-08
Publications
- Background Ali M, Rasool S, Park JK, Saeed S, Ochiai RL, Nizami Q, Acosta CJ, Bhutta Z. Use of satellite imagery in constructing a household GIS database for health studies in Karachi, Pakistan. Int J Health Geogr. 2004 Sep 28;3(1):20. doi: 10.1186/1476-072X-3-20.
- Background Acosta CJ, Galindo CM, Ochiai RL, Danovaro-Holliday MC, Page AL, Thiem VD, Park JK, Park E, Koo H, Wang XY, Abu-Elyazeed R, Ali M, Albert MJ, Ivanoff B, Pang T, Xu ZY, Clemens JD. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia. J Health Popul Nutr. 2004 Sep;22(3):240-5.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Havrix | Vaccine | 720 unknown | — |
| Subject | Typhoid Vi vaccine | Vaccine | 25 ug | — |